Indigenous Knowledge and Biopiracy: Protecting the World’s Traditional Wisdom

For centuries, a farmer in Kerala has known which leaf soothes a wound, and a grandmother in Punjab has known which rice variety carries the best aroma. This knowledge was never written in a patent office ledger. It was passed down through generations, freely shared, and treated as a common inheritance. Yet in the 1990s, corporations and researchers in other countries began locking this very knowledge behind patents, claiming it as their own “invention.” This practice has a name: biopiracy. It sits at the uncomfortable intersection of science, law, economics, and cultural survival, and it raises a difficult question about who truly owns the wisdom that communities have nurtured for thousands of years.

Defining biopiracy 🔗

Biopiracy is the unauthorised appropriation of biological resources or the traditional knowledge of indigenous and local communities, usually by individuals or corporations, through patents or other intellectual property claims, without fair compensation or consent. In simple terms, it happens when someone takes a plant, a microorganism, or the knowledge surrounding its use, and then claims exclusive commercial rights over it, even though communities have used it openly for generations.

To understand why this is a problem, it helps to understand how the patent system works. A patent is meant to reward genuine novelty and non-obviousness, an invention that did not exist before. Traditional knowledge fails this test by definition, because it is already known and already in use. When a patent office in another country grants rights over such knowledge, it effectively privatises something that was always public. The knowledge existed; it was simply recorded in Sanskrit, Tamil, Urdu, or Hindi texts that foreign patent examiners could neither access nor read.

Why this knowledge slips through the cracks 🔗

The core vulnerability is a gap in documentation and language. India’s traditional medicinal knowledge exists in local languages that are neither accessible nor comprehensible to patent examiners in the United States, Europe, or Japan. As a result, an examiner reviewing a patent application may genuinely believe a claim is new, simply because the “prior art” proving otherwise is locked away in ancient texts they cannot search. An expert group identified that around 2,000 patents relating to Indian systems of medicine were being granted erroneously each year by patent offices around the world.

Biopiracy is not always a single act. Some cases involve commercial biopiracy, the unauthorised commercial use of native plants and animals. Others involve bioprospecting, the search for valuable biological material, conducted without sharing any benefits with the source community. The common thread is appropriation without permission, credit, or compensation.

Prominent cases of biopiracy 🔗

The most powerful way to understand biopiracy is through the landmark disputes that shaped how the world now thinks about traditional knowledge. Several of these involve everyday items found in almost every Indian kitchen.

The turmeric case 🔗

In 1995, the US Patent and Trademark Office granted a patent for the wound-healing properties of turmeric to two researchers working at the University of Mississippi Medical Center. The problem was obvious to anyone familiar with Indian households, where turmeric had been used to treat burns and rashes for centuries. The Council of Scientific and Industrial Research (CSIR) challenged the patent by producing extensive documentary evidence, including references from ancient Sanskrit and Urdu texts, to prove the use was old and well known. The patent was eventually revoked because it lacked novelty. This case became a turning point, alerting countries everywhere to the urgent need to protect traditional knowledge.

The neem case 🔗

Neem has been used for centuries as a natural pesticide and a staple of traditional medicine. In 1994, the European Patent Office granted a patent to the US corporation W.R. Grace and the US Department of Agriculture for a method of controlling fungi on plants using extracted neem oil. A legal opposition was filed by the New Delhi-based Research Foundation for Science, Technology and Ecology, alongside international partners. After a long battle, the patent was revoked. The campaigner Vandana Shiva captured the sentiment of the movement when she described the dispute as a fight to keep “the free tree” free.

The basmati case 🔗

The basmati case is different in an important way. In 1997, the American company RiceTec was granted a US patent on certain basmati rice lines and grains. This was not the patenting of knowledge but an attempt to appropriate genetic resources and the reputation of a geographically specific product. India challenged the claims, and RiceTec ultimately withdrew the majority of its claims. The case directly influenced the strengthening of the Geographical Indications of Goods (Registration and Protection) Act, 1999, which gives legal protection to products tied to a specific geographic origin.

These victories were not free. Revoking the turmeric patent alone took roughly two years and considerable money and diplomatic effort, requiring the assembly of dozens of references from ancient texts. This cost reveals an uncomfortable truth: communities must spend enormous resources simply to reclaim what was already theirs.

Economic and cultural implications 🔗

Biopiracy is often discussed as a legal puzzle, but its consequences are deeply economic and cultural. When a corporation patents a remedy or a crop variety, it gains the exclusive right to commercialise it. The community that developed and preserved that knowledge over generations receives nothing, even though their stewardship made the resource valuable in the first place.

The economic cost 🔗

The financial loss works in two directions. First, communities are denied a share of the profits generated from their own heritage. A herbal formulation that becomes a commercial product can earn substantial revenue, none of which flows back to its originators. Second, patents can restrict the community’s own ability to use or develop the resource. In the neem dispute, the concern was precisely this: India, despite having used the tree for centuries, risked losing the legal freedom to develop it for its own medicinal and agricultural purposes.

There is also a question of fairness in development economics. Many of the world’s biodiversity-rich nations are developing countries, while many of the corporations filing patents are based in wealthier ones. Biopiracy can therefore widen the gap between rich and poor nations, transferring value from communities that conserve biodiversity to companies that commercialise it.

The cultural and ecological cost 🔗

The damage is not only monetary. Traditional knowledge is woven into the cultural identity of indigenous communities. It is part of their language, their rituals, their relationship with the land, and their sense of who they are. When this knowledge is taken and turned into private property, it strips communities of recognition and erodes the cultural systems that sustained it.

There is an environmental dimension too. Biopiracy can encourage the overuse of biological resources without regard for long-term sustainability, which can deplete those resources and damage the ecosystems that depend on them. Communities that have managed biodiversity sustainably for generations may find their resources exploited far more aggressively once commercial interests take over.

Strategies for protecting indigenous rights 🔗

The wave of biopiracy cases in the 1990s triggered a serious global and national response. Today, a layered system of databases, national laws, and international treaties exists to defend traditional knowledge, though gaps remain.

The Traditional Knowledge Digital Library 🔗

One of the most effective defensive tools is the Traditional Knowledge Digital Library (TKDL). This database converts the contents of ancient texts on Ayurveda, Siddha, Unani, and Yoga into multiple international languages, including English, Japanese, French, German, and Spanish, using an innovative classification system. By making this knowledge searchable for patent examiners, the TKDL allows offices worldwide to reject wrongful patent applications before they are even granted. The library now holds a vast collection of formulations and has helped block hundreds of questionable patent claims. It works as a shield: instead of fighting expensive battles after a patent is granted, the knowledge is now visible as prior art from the start.

National law: the Biological Diversity Act 🔗

India enacted the Biological Diversity Act in 2002 specifically to prevent the misappropriation of genetic resources and the traditional knowledge of local communities, and to end biopiracy. The Act has been described as a model legislation for many developing countries. It establishes a three-tier structure: the National Biodiversity Authority at the national level, State Biodiversity Boards at the state level, and Biodiversity Management Committees at the local level. Anyone seeking to access India’s biological resources for research or commercial use must obtain prior approval and agree to share the benefits fairly.

Benefit sharing in action: the Kani model 🔗

Protection is not only about blocking patents; it can also mean ensuring communities share in the rewards. A widely cited example is the Jeevani case involving the Kani tribe of Kerala. Jeevani is a herbal remedy derived from the Arogyapacha plant, traditionally used by the Kani for energy and vitality. The Tropical Botanic Garden and Research Institute collaborated with the community to develop the product, and the resulting agreement was groundbreaking because it shared the commercial benefits with the tribe. This stands as a positive counter-example to biopiracy, showing how access and benefit sharing can work when consent and fairness are built in from the start.

International frameworks: the CBD, Nagoya Protocol, and the 2024 WIPO Treaty 🔗

At the global level, the Convention on Biological Diversity established the principle of fair and equitable benefit sharing. Building on it, the Nagoya Protocol, adopted in 2010, recognises local and indigenous communities as eligible benefit claimers and requires their consent before their resources or associated knowledge can be accessed. India ratified the Protocol in 2012 and has embedded its principles in domestic law.

The most recent and significant development arrived in May 2024, when WIPO member states adopted the first treaty to deal specifically with genetic resources and traditional knowledge held by indigenous peoples. Borne of a proposal made by Colombia back in 1999, it was the first new WIPO treaty in over a decade. Its core mechanism is a mandatory disclosure requirement: patent applicants whose inventions are based on genetic resources or associated traditional knowledge must reveal the country of origin and the community that provided the knowledge. This treaty matters greatly to India, a country that holds a significant share of global biodiversity. By forcing transparency at the application stage, the disclosure rule aims to stop biopiracy before a wrongful patent is ever issued.

Together, these tools represent a shift from reactive battles toward proactive protection. The TKDL prevents wrongful grants, national laws regulate access and demand benefit sharing, and the new international treaty pushes the entire global patent system toward disclosure and accountability.

What do you think? If a community has freely shared its knowledge for generations, who should hold the right to profit from it once it becomes commercially valuable, and how do we measure a “fair” share? And as more traditional knowledge gets digitised into databases to protect it, do we risk making it easier to exploit even as we make it easier to defend?

References

1. https://www.mondaq.com/india/patent/586384/traditional-knowledge-and-patent-issues-an-overview-of-turmeric-basmati-neem-cases
2. https://www.iiprd.com/patenting-of-traditional-knowledge-in-light-of-the-turmeric-case/
3. https://www.lexology.com/library/detail.aspx?g=1c132aa5-97af-4164-af22-ca3c240ab172
4. https://www.nlunagpur.ac.in/PDF/Publications/5-Current-Issue/5.BIO-PIRACY%20IN%20INDIA%20A%20PRACTICE%20OF%20PATENTING%20TRADITIONAL%20KNOWLEDGE%20FOR%20PROFIT.pdf
5. https://www.legacyias.com/biopiracy-neem-turmeric-case-studies-upsc-notes/
6. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3048709
7. https://www.lexology.com/library/detail.aspx?g=88e00ba9-d3c8-43dc-a6af-f76d62bd0aed
8. https://clpr.org.in/blog/towards-compliance-the-nagoya-protocol-and-the-biological-diversity-act/
9. https://www.downtoearth.org.in/wildlife-biodiversity/wipo-meeting-2024-new-treaty-on-genetic-resources-and-associated-traditional-knowledge-in-place-96348